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Purpose: This study was performed to test whether tenascin, alarge oligomeric glycopro- 
tein of the extracellular matrix, is present in AAA disease and whether it could play a 
pathophysiologic role in the development of this disease. 
Methods: Tenascin immunoreactivity was investigated from samples of the aneurysmal 
walls of 17 patients with AAAs, and the results were compared with the results of those of 
six patients with aortoiliac occlusive disease (AOD) and one normal control patient. To 
study the source of tenascin mRNA synthesis, some tissue samples were also examined 
with a tenascin RNA probe by in situ hybridization. 
Results: The difference in immunoreactivity between the AODs and AAAs was especially 
prominent in the adventitial layer, where the specimens from AAAs displayed strong 
diffuse and reticular hnmunostaining. In AAAs the immunostaining was dearly associ- 
ated with the degree of mononuclear inflammatory cell infiltrate and with the neovascu- 
larization of the adventitial layer. 
Conclusion: Tenascin expression is evident in AAA disease and is distinctly associated with 
mononuclear inflammatory cells. The adhesive properties of tenascin may offer a relevant 
explanation for the mechanism by which monocytes transmigrate in othe aortic wall. 
The definitive role of tenascin in AAA process may be more complex, however, and will 
necessitate further investigation. (J Vasc Surg 1997;26:670-5.) 
Although a chronic inflammatory infiltrate of 
varying intensity is ubiquitous in the wall of abdom- 
inal aortic aneurysms (Aaas), 1,2 the specific factors 
that initially attract these cells remain unknown. 
Chemotaxis produced by elastin-derived peptides 
may serve as one explanation, being a potent stimu- 
lus for monocyte infiltration in cases of  AAA? ,4 Vas- 
cular adhesion molecules are also assumed to play an 
important role in this process, participating in the 
attachment of mononuclear cells and their passage 
across endothelial cellsfi 
Tenascin is a large oligomeric glycoprotein of the 
extracellular matrix with a molecular weight of 1900 
kD 6 that is found in embryonic tissues, especially at 
epithelial-mesenchymal junctions, and in developing 
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brain tissue, where it probably plays a role in epithe- 
lial-mesenchymal induction and migration. 6,7 In 
adult tissues it becomes confined to the perichon- 
drium and periosteum, ligaments, tendons, and 
myotendinous junctions. 8 The widespread istribu- 
tion of tenascin in a number of physiologic and 
pathologic states uggests that it plays an important 
part in stromal tissue interactions. It probably serves 
such important functions as cellular motility and dif- 
ferentiation. It is present in tumors and healing 
wounds, and its reparative association reflects adhe- 
sive properties. It has been recently proposed that 
tenascin expression i  AAAs may indicate the process 
manifested as angiogenesis. 9 
The aim of the present survey was to test whether 
tenascin is present in AAA disease and whether it 
could play pathophysiologic role in the development 
of this disease. For this purpose, immunostained 
samples from the aneurysmal walls of 17 patients 
with AAAs were examined, and the results were com- 
pared with those of  six patients with aortoiliac occlu- 
sive disease (AOD) and one normal control patient. 
To study the source of tenascin mRNA synthesis, we 
also examined some tissue samples with a tenascin 
RNA probe by in situ hybridization. 
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MATERIAL AND METHODS 
Full-thiclmess longitudinal strips from the ante- 
rior wall of the infrarenal aorta were obtained from 
17 patients (14 men; mean age, 69 years; range, 59 
to 79 years) who underwent aortic reconstruction for
noninflammatory and fusiform AAAs at the Depart- 
ment of Surgery of Oulu University Hospital. The 
aneurysm specimens were compared with ones from 
patients who had AOD (n = 6; four men; mean age, 
54 years; range, 40 to 71 years) and with one speci- 
men obtained at autopsy within 24 hours of death 
from a 16-year-old boy who had died in a car acci- 
dent. All the AAA and AOD specimens were taken in 
the operation room before repair, fixed in 10% buff- 
ered formalin, and embedded in paraffin. 
For the purposes of immunostaining, 5 Izm sec- 
tions were deparaffinized in xylene and rehydratcd in
graded alcohol. The endogenous peroxidase was 
consumed by treating with 0.3% hydrogen peroxide 
in absolute methanol for 30 minutes. The sections 
were treated with 0.4% pepsin (Merck, Darmstadt) at 
37°C for 30 minutes before immunostaining by 
the avidin-biotin peroxidase method with monoclo- 
nal mouse antibody (Mab) to human tenascin 
(143DB7). 1° The sections were incubated with this 
primary antibody at 4 ° C overnight, followed by bi- 
otinylated rabbit antimouse antibody and the avidin- 
biotin peroxidase complex (Dakopatts, Glostrup, 
Denmark). Diaminobenzidine was used as a chromo- 
gen and the sections were lightly counterstained with 
hematoxylin. Negative controls were obtained by 
substituting phosphate-buffered saline solution (140 
ml NaC1, 0.01 mol/L phosphate buffer, pH 7.2) and 
normal mouse serum for the primary antibody. The 
tenascin immunoreactivity findings were grouped 
semiquantitatively by two independent pathologists 
as follows:-, no immunoreactivity; +, weak; ++, 
moderate; ++ +, strong. 
A cDNA clone HT l l  encompassing the bases 
793-2916, akind gift from Dr. Luciano Zardi, Insti- 
tuto Nazionale Per La Ricerca Sul Cancro, Genova, 
Italy, was used to prepare RNA probes for in situ 
hybridization. 11 A 502 bp fragment, encompassing 
bases 814 to 1316, was amplified by polymerase 
chain reaction (PCR) using the primers 5'CCCTG- 
CAGTGAGCACGGCACA3' and 5'TGCCCATT- 
GACACAGCGGCCATGG3'. The PCR products 
were further subcloned into the TA vector (TA 
Cloning Kit, Invitrogen Inc., USA), which includes 
the SP6 and T7 RNA polymerase promoter sites. 
The template was linearized with the NcoI (Biolabs, 
USA; T7) and MunI (Fermentas, Lithuania; SP6) 
restriction enzymes. The RNA probes were tran- 
scribed using a ribiprobe transcription kit (Promega, 
USA) and were labeled with S-35 UTP (Amersham) 
to a specific activity of more than 3 × 108 cpm. All 
the solutions used with the RNA probes were treated 
with 0.1% diethylpyrocarbonate (Fluka). In situ hy- 
bridization with antisense (SP6) and sense (T7) 
probes was performed according to the protocols of 
Hogan et al. 12 and Hoeffier et al., 13 with minor 
modifications. The hybridizadLon, posthybridization 
washes, and detection of the hybrids follows the 
protocols described in detail by Autio-Harmainen ,t
al. 14 
Immunophenotypic analysis of inflammatory 
cells in the aorta samples required the use of four 
monoclonal mouse antibodies (UCHL1, L26, PG- 
M1, and KP1) obtained from Dako (Glostrup, Den- 
mark). UCHL1 (anti-CD45) labels resting T cells 
within both the CD4 and CD8 subsets and mature 
activated T cells, whereas L26 (anti-CD20) is di- 
rected against an antigen present on the majority of 
B cells. Both PG-M1 and KP1 stain macrophages 
and gave essentially identical results in our stainings. 
All these antibodies were used at a dilution of 1:50. 
Neutrophils were recognized ,an the basis of positiv- 
ity in periodic acid-Schiff (PAS) staining. Inflamma- 
tion was also assessed on a semiquantitative scale by 
two independent pathologists as follows: -, no in- 
flammation; +, mild; ++, moderate; +++,  abun- 
dant inflammatory ceil infiltrate. 
RESULTS 
The histologic sections through the walls of the 
AAAs showed considerable thinning of the media, 
with smooth muscle cell diminution and expression 
of medioadventitial fibrosis and variable inflamma- 
tion. The inflammatory infiltrate was mainly mono- 
nuclear and was commonly located at the junction of 
the media and adventitia. Immunophenotypic analy- 
sis of the inflammatory cells demonstrated the pres- 
ence ofT cells, B cells, and macrophages in variable 
numbers and only occasional neutrophils. Inflamma- 
tion was very slight or absent in the AOD specimens, 
and no appreciable inflammation was seen in the 
normal control aorta. An outstanding feature of the 
AAA specimens was the presence of small capillaries, 
indicating angiogenesis. 
The results of the tenascin immunostaining are 
shown in Table I. Weak linear' tenascin immunoreac- 
tivity could been seen in the smooth muscle cells of 
the media of the normal aortic wall. Strong linear 
immunostaining could be seen in the atherosclerotic 
plaques of the AODs, but only weak linear immuno- 
reactivity in the adventitial layers, whereas there was 
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Table I. Results of tenascin immunostaining and its relation to mononuclear inflammation 
.@e 
Male~female (y r )  D iagnos is  Diameter Inflammation Tenascin immunoreactivity Fibrosis 
Female 60 AOD - -  + + + 
Female 43 AOD - -  - + - 
Male 40 AOD - -  - + + 
Male 48 AOD . . . .  
Male 50 AOD - -  - + + + 
Male 56 AOD - -  - + + 
Female 63 AAA 5.0 + + + + + + + + + 
Female 70 AAA 5.0 + + + + + + 
Female 79 AAA 6.0 + + + + + + + + 
Male 59 AAA 6.0 +++ +++ +++ 
Male 60 AAA 5.0 + + + + + + + 
Male 63 AAA 5.0 +++ +++ ++ 
Male 65 AAA 5.0 +++ ++ ++ 
Male 65 AAA 6.0 + + + + + + 
Male 67 AAA 5.5 + + + + + 
Male 7 I  AAA 4.8 + + + + + + 
Male 75 AAA 6.0 ++ +++ ++ 
Male 75 AAA 7.0 +++ +++ ++ 
Male 68 AAA 6.4 ++ +++ ++ 
Male 73 AAA 5.8 ++ +++ +++ 
Male 77 AAA 6.0 + + + + 
Male 74 AAA 6.5 +++ +++ + 
Male 69 A_AA 5.5 + + + + + + + 
Male 16 Control  . . . .  
strong immunoreactivity throughout the aortic wall 
in the all AAA cases. The difference between the 
AODs and AAAs was especially prominent in the 
adventitial layer, where specimens from AAAs dis- 
played strong diffuse and reticular immunostaining 
(Figs. 1 and 2). This difference was also significant 
statistically (2o = 0.0002, Fisher's exact test). The 
difference in the extent of immunoreactivity was 
clearly associated with the degree of inflammation i
the adventitia (Table I): There was also a strong 
neovascularization in the adventitial layer of the 
AAAs, and the walls of the small capillaries displayed 
strong immunostaining (Fig. 2). 
The mRNA signals for tenascin were in general 
comparatively weak, suggesting that the mRNA level 
required for maintaining a suitable protein concen- 
tration in the tissues is low. Clear in situ hybridiza- 
tion signals were seen in the mesenchymal cells and 
endothelial cells, however, which suggests that it is 
these that are responsible for the mRNA synthesis n 
AAA (Fig. 3). 
DISCUSSION 
The present results point to a clcar association 
betwecn a chronic aneurysmal inflammatory process 
and tcnascin immunoreactivity. The expression of 
ncovascularization was also connccted with these 
two factors, although in a less prominent manner. 
Chronic inflammation is a common finding in 
human AAA tissues, and the importance of the in- 
flammatory cellular infiltrate may lie in its potential 
modulation of endothelial nd vascular smooth mus- 
cle cell function through the cytoldne network. In 
addition, the chronic nature of the inflammation may 
suggest direct release of matrix metalloproteinases in 
AAA disease or a possible immune-mediated mecha- 
nism. Because human AAAs represent an advanced 
or end-stage disease, it remains unclear whether 
these inflammatory cells are involved in the initiation 
or progression of aneurysmal degeneration. An ex- 
perimental in vivo aneurysm odel in rats has never- 
theless enabled us to understand better the chrono- 
logic aspects of the inflammatory process in the 
pathogenetic chain of AAA, connecting it to the very 
initial phenomena in that cascade3 s Furthermore, 
mononuclear cell accumulation is Imown to be asso- 
ciated with angiogenesis, which consists of the re- 
cruitment and proliferation of endothelial cells. 16 
Neovascularization itself may have a significant fur- 
ther implication in the AAA process in addition to 
being a marked inflammatory esponse, as it is asso- 
ciated with an elevated production of matrix-metal- 
loproteinases, which may exacerbate matrix degrada- 
tion. 
The specific factors that initially attract macro- 
phages and lymphocytes into the aortic wall remain 
unknown. Degradation of elastic matrices may serve 
as a potent stimulus to infiltration through local 
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Fig. 1. Low-power view of tenascin immunoreactivity in aneurysmal wall shows strong stain- 
ing throughout wall. Linear diffuse immunoreactivity is observed in atherosclerotic intima and 
fibrotic media. There is strong inflammation i adventitial layer, and immunostaining is more 
reticular. 
Fig. 2. High-power view of tenascin immunostaining in adventitial layer of aneurysmal wall. 
There is diffuse linear stromal immunoreactivity. Walls of small capillaries stain strongly for 
tenascin. 
release of chemotactic elastin-derived peptides, i7
Our results also indicate another possible xplanation 
for the mechanics of cellular accumulation i  aneu- 
rysmal aortic wall by emphasizing the function of 
tenascin in the extracellular matrix. Tenascin is 
known to be able to bind to ther molecules of  the 
ECM and to possess a distinctive tissue distribution 
during development, being present at the times and 
places of morphogenetic tissue interactions and 
movements? 8 Regardless of the discrepancy in its 
contribution to lymphatic tissue, it is known to be 
able to exert important immunomodulatory activities 
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Fig. 3. Positive signals for tenascin mRNA can be seen in endothelial and fibroblastic cells in 
middle field. 
on T and B cells and macrophages) 9 Consequently, 
the association of inflammatory cells and tenascin 
with microcapillaries in aneurysmal ortic walls may 
include adhesion, resulting in monocytes rolling 
along the endothelial surface, and then tight adher- 
ence of cells, resulting in immobilization and trans- 
migration across the endothelimn to the inner layers 
by a route provided by these microvessels. 
The chronologic ausality between inflammation 
and tenascin expression may be also reversed. The 
present in situ hybridization experiment indicated 
that the synthetic activity of tenascin in the AAA 
walls is localized to the microcapillary-related endo- 
thelial and mesenchymal cells. It is known that tena- 
scin synthesis i  regulated by many growth factors: 
interleuldn-1, interleuldn-4, tumor necrosis factor- 
alpha, activin and platelet-derived growth factor, 
which are products of inflammatory and mesenchy- 
mal cells? ° These growth factors may then cause 
accelerated tenascin synthesis by fibroblast induc- 
tion. 8 
A recent experimental study has shown that the 
induction of fibroblasts may also be adjusted by me- 
chanical forces, so that mechanical strain exerted by 
fibroblasts in restrained collagen gels induced the 
expression oftenascin. 21This could provide a mech- 
anism for translating mechanical forces into protein 
patterns. The strain produced by the pulse pressure 
in the abdominal aorta may accelerate tenascin syn- 
thesis and may serve as a further indication to hemo- 
dynamic influence on AAA progression. 
Besides the adhesive properties of tenascin, the 
significance of its expression i  AAA may be a result 
of direct accelerated proteolysis. It  lmown that the 
presence of tenascin induces the secretion of colla- 
genases in fibroblasts, 22and this subsequently results 
in structural alterations in the extracellular matrix 
proteins. 
CONCLUSION 
Tenascin expression isevident in AAA disease and 
is distinctly associated with mononuclear inflamma- 
tory cells. Accordingly, the adhesive properties of 
tenascin may offer a relevant explanation for the 
mechanism by which monocytes transmigrate into 
the aortic wall. The role of tenascin in AAA process 
may be more complex, however, and will necessitate 
further investigation. 
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